Newsfiscal.ai
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine
· Published
Article summary
Seres Therapeutics reported that results from its Phase 1b clinical study of SER-155 in patients undergoing allogeneic hematopoietic cell transplantation were published in Nature Medicine.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…